J 2022

Screening for obstructive sleep apnoea in high-risk patients with mood disorders

VANĚK, Jakub, Ján PRAŠKO PAVLOV, Marie OCISKOVÁ, Samuel GENZOR, Eliška SOVOVÁ et. al.

Basic information

Original name

Screening for obstructive sleep apnoea in high-risk patients with mood disorders

Authors

VANĚK, Jakub (203 Czech Republic), Ján PRAŠKO PAVLOV (203 Czech Republic), Marie OCISKOVÁ (203 Czech Republic), Samuel GENZOR (203 Czech Republic), Eliška SOVOVÁ (203 Czech Republic), Milan SOVA (203 Czech Republic, belonging to the institution), Kamila BĚLOHRADOVÁ MINAŘÍKOVÁ (203 Czech Republic), Vlastimil NESNÍDAL (203 Czech Republic), Jonáš BOČEK (203 Czech Republic), Kryštof KANTOR (203 Czech Republic) and Veronika ONDRÁČKOVÁ DACEROVÁ (203 Czech Republic, guarantor, belonging to the institution)

Edition

Neuroendocrinology letters, LUXEMBOURG, MAGHIRA & MAAS PUBLICATIONS, 2022, 0172-780X

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30103 Neurosciences

Country of publisher

Sweden

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 0.700

RIV identification code

RIV/00216224:14210/22:00128438

Organization unit

Faculty of Arts

UT WoS

000942361700004

Keywords in English

sleep apnoea; OSA; depression; bipolar disorder; screening; obesity; snoring

Tags

International impact, Reviewed
Změněno: 4/4/2023 09:45, Mgr. Tereza Miškechová

Abstract

V originále

Objective: Our study aimed to screen for obstructive sleep apnoea (OSA) in a clinical population of psychiatric patients with affective disorders and risk factors for OSA using screening devices in psychiatric clinical environments. Methods: Inpatients admitted with mood disorders in an inpatient psychiatric department were selected via inclusion and exclusion criteria and assessed for the risk factors of OSA. The inclusion criteria were: a diagnosis of an affective disorder confirmed by two independent psychiatrists, snoring or apnoeic pauses witnessed during regular night check-ups by nurses, and BMI > 25. The exclusion criteria were: a comorbid psychotic disorder, previously diagnosed OSA, intellectual disability, organic mental disorder, acute coronary syndrome, acute or chronic heart failure, acute pulmonary diseases, a history of stroke, neuromuscular disorders, or a myorelaxant treatment. All included patients underwent overnight monitoring by a screening device SomnoCHECK Micro Cardio. A certified somnologist assessed obtained data. Results: A total of 32 subjects (23 women and 9 men) were included in the study. The mean age was 49.8 ± 8.8 years. Most of the participants had major depressive disorder (n = 23); another nine individuals had bipolar disorder. Diagnostic criteria for OSA were found in 50% of the sample, specifically in 85% men and 33% women. The correlation analysis identified several risk factors and variables. Conclusion: This pilot study showed an increased risk of OSA in patients with mood disorders. Psychiatric patients with identified risk factors should be routinely screened for obstructive sleep apnoea and referred to proper treatment.